Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less

Journal of Urology

Volumn 161, Issue 3, 1999, Pages 835-839

  Carvalhal, Gustavo F ^a   Smith, Deborah S ^a   Mager, Douglas E ^a   Ramos, Christian ^a   Catalona, William J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; FINGER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE; RECTUM; REGRESSION ANALYSIS;

EID: 0032853665     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61785-3     Document Type: Article

References (20)

1. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1998. CA, 48: 6, 1998.
2. Optenberg, S. A. and Thompson, I. M.: Economics of screening for carcinoma of the prostate. Urol. Clin. N. Amer., 17: 719, 1990.
3. Jacobsen, S. J., Katusic, S. K., Bergstralh, E. J., Oesterling, J. E., Ohrt, D., Klee, G. G., Chute, C. G. and Lieber, M. M.: Incidence of prostate cancer diagnosis in the eras before and after prostate-specific antigen testing. J.A.M.A., 274: 1445, 1995.
4. Smith, D. S., Humphrey, P. A. and Catalona, W. J.: The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience. Cancer, 80: 1852, 1997.
5. Gann, P. H., Hennekens, C. H. and Stampfer, M. J.: A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. J.A.M.A., 273: 289, 1995.
6. Smith, D. S., Catalona, W. J. and Herschman, J. D.: Longitudinal screening for prostate cancer with prostate-specific antigen. J.A.M.A., 276: 1309, 1996.
7. Harris, C. H., Dalkin, B. L., Martin, E., Marx, P. C. and Ahmann, F. R.: Prospective longitudinal evaluation of men with initial prostate specific antigen levels of 4.0 ng/ml or less. J. Urol., 157: 1740, 1996.
8. Carter, H. B., Epstein, J. I., Chan, D. W., Fozard, J. L. and Pearson, J. D.: Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer. J.A.M.A., 277: 1456, 1997.
9. Gerber, G. S., Thompson, I. M., Thisted, R. and Chodak, G. W.: Disease-specific survival following routine prostate cancer screening by digital rectal examination. J.A.M.A., 269: 61, 1993.
10. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicentric clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
11. Coley, C. M., Barry, M. J., Fleming, C. and Mulley, A. G.: Early detection of prostate cancer: prior probability and effectiveness of tests. Ann. Internal Med., 126: 394, 1997.
12. Chodak, G. W., Keller, P. and Schoenberg, H. W.: Assessment of screening for prostate cancer using the digital rectal examination. J. Urol., 141: 1136, 1989.
13. Smith, D. S. and Catalona, W. J.: Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology, 45: 70, 1995.
14. Underwood, S. M.: African-American men: perceptual determinants of early cancer detection and cancer risk reduction. Cancer Nurs., 14: 281, 1991.
15. Schroeder, F. H., Kruger, A. B., Hoedemacker, R. F., Kranse, R. and Rietbergen, J.: European randomized study of screening for prostate cancer (ERSPC): the accuracy of DRE and PSA transition zone density in diagnosing prostate cancer. J. Urol., part 2, 159: 233, abstract 891, 1998.
16. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A., 270: 948, 1993.
17. Krahn, M. D., Mahoney, J. E., Eckman, M. H., Trachtenberg, J., Pauker, S. G. and Detsky, A. S.: Screening for prostate cancer: a decision analytic view. J.A.M.A., 272: 773, 1994.
18. Littrup, P. J.: Future benefits and cost-effectiveness of prostate carcinoma screening. Cancer, 80: 1864, 1997.
19. Smith, D. S., Bullock, A. D. and Catalona, W. J.: Racial differences in operating characteristics of prostate cancer screening tests. J. Urol., 158: 1861, 1997.
20. Parker, S. L., Davis, K. J., Wingo, P. A., Ries, L. A. G. and Heath, C. W., Jr.: Cancer statistics by race and ethnicity. CA, 48: 31, 1998.